In re Buspirone Antitrust Litigation
Louisiana Wholesale Drug Co., In.c v. Bristol-Myeyers Squib Co., et al., Civil Action No. 01-CV-7951 (S.D.N.Y.) Hon John G. Koeltl)


Challenging Bristol-Myers Squibb's alleged unlawful acts to prevent the marketing and sale of a generic version of busiprone hydrocholoride.

Garwin, Bronzaft, Gerstein & Fisher, L.L.P. is co-lead counsel in this case.

View the current settlement documents

SUMMARY NOTICE OF PROPOSED DIRECT PURCHASER CLASS ACTION SETTLEMENT AND HEARING REGARDING SETTLEMENT

NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION AND HEARING REGARDING SETTLEMENT

SETTLEMENT AGREEMENT (Corrected)

PRINTABLE REQUEST FOR EXCLUSION FORM